LHC Group (NASDAQ:LHCG) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a research note issued on Friday.

According to Zacks, “LHC Group provides post-acute healthcare services primarily to Medicare beneficiaries in rural markets in the southern United States. They provide home-based services through their home nursing agencies and hospices and facility-based services through their long-term acute care hospitals and outpatient rehabilitation clinics. “

A number of other equities research analysts have also recently issued reports on LHCG. Jefferies Group LLC boosted their price objective on LHC Group from $68.00 to $83.00 and gave the stock a “buy” rating in a report on Tuesday, November 7th. They noted that the move was a valuation call. Royal Bank Of Canada boosted their price objective on LHC Group from $70.00 to $81.00 and gave the stock an “outperform” rating in a report on Tuesday, November 7th. Oppenheimer Holdings, Inc. boosted their price objective on LHC Group from $68.00 to $80.00 and gave the stock an “outperform” rating in a report on Tuesday, November 7th. Craig Hallum restated a “buy” rating and set a $80.00 price objective (up previously from $67.00) on shares of LHC Group in a report on Tuesday, November 7th. Finally, Bank of America Corporation assumed coverage on LHC Group in a report on Monday, August 21st. They set a “buy” rating and a $76.00 price objective for the company. Two equities research analysts have rated the stock with a hold rating and nine have issued a buy rating to the company. The company currently has an average rating of “Buy” and a consensus target price of $76.40.

Shares of LHC Group (LHCG) traded down $1.26 during trading hours on Friday, hitting $66.26. The stock had a trading volume of 182,600 shares, compared to its average volume of 162,560. LHC Group has a 12 month low of $41.66 and a 12 month high of $76.14. The company has a market capitalization of $1,211.23, a PE ratio of 28.44, a PEG ratio of 1.96 and a beta of 0.70. The company has a current ratio of 1.77, a quick ratio of 1.75 and a debt-to-equity ratio of 0.24.

LHC Group (NASDAQ:LHCG) last issued its quarterly earnings data on Monday, November 6th. The health services provider reported $0.64 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.60 by $0.04. LHC Group had a return on equity of 9.52% and a net margin of 4.09%. The company had revenue of $272.90 million during the quarter, compared to analysts’ expectations of $265.35 million. During the same quarter in the previous year, the company posted $0.54 earnings per share. The business’s revenue was up 18.2% on a year-over-year basis. analysts forecast that LHC Group will post 2.4 earnings per share for the current year.

WARNING: “LHC Group (LHCG) Stock Rating Lowered by Zacks Investment Research” was posted by Watch List News and is owned by of Watch List News. If you are accessing this article on another domain, it was illegally copied and republished in violation of international trademark & copyright law. The legal version of this article can be accessed at https://www.watchlistnews.com/lhc-group-lhcg-stock-rating-lowered-by-zacks-investment-research/1698872.html.

In related news, COO Donald Dwayne Stelly sold 2,650 shares of the business’s stock in a transaction that occurred on Friday, September 8th. The stock was sold at an average price of $65.34, for a total value of $173,151.00. Following the completion of the sale, the chief operating officer now directly owns 109,235 shares in the company, valued at $7,137,414.90. The sale was disclosed in a filing with the SEC, which is available at this link. Insiders own 14.80% of the company’s stock.

Hedge funds have recently modified their holdings of the stock. Alps Advisors Inc. raised its position in LHC Group by 0.3% during the second quarter. Alps Advisors Inc. now owns 9,449 shares of the health services provider’s stock valued at $641,000 after purchasing an additional 24 shares in the last quarter. Federated Investors Inc. PA raised its position in LHC Group by 4.2% during the second quarter. Federated Investors Inc. PA now owns 1,622 shares of the health services provider’s stock valued at $110,000 after purchasing an additional 66 shares in the last quarter. Arizona State Retirement System raised its position in LHC Group by 1.3% during the second quarter. Arizona State Retirement System now owns 7,818 shares of the health services provider’s stock valued at $531,000 after purchasing an additional 100 shares in the last quarter. Victory Capital Management Inc. raised its position in LHC Group by 0.3% during the second quarter. Victory Capital Management Inc. now owns 48,920 shares of the health services provider’s stock valued at $3,321,000 after purchasing an additional 142 shares in the last quarter. Finally, Texas Permanent School Fund raised its position in LHC Group by 1.4% during the second quarter. Texas Permanent School Fund now owns 10,944 shares of the health services provider’s stock valued at $743,000 after purchasing an additional 153 shares in the last quarter. Institutional investors and hedge funds own 87.32% of the company’s stock.

About LHC Group

LHC Group, Inc is a holding company. The Company provides post-acute healthcare services to patients through its home nursing agencies, hospice agencies, community-based services agencies and long-term acute care hospitals (LTACHs). The Company operates through four segments: home health services, hospice services, community-based services and facility-based services.

Analyst Recommendations for LHC Group (NASDAQ:LHCG)

Receive News & Ratings for LHC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group and related companies with Analyst Ratings Network's FREE daily email newsletter.